Tempest Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 10-12-2024
- Paid Up Capital ₹ 2.50 M
as on 10-12-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Tempest Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Buddhadeb Chakraborty and Rishab Jaiswal serve as directors at the Company.
- CIN/LLPIN
U24232WB2007PTC116075
- Company No.
116075
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tempest Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Buddhadeb Chakraborty  | Director | 10-Jun-2023 | Current |
| Rishab Jaiswal | Director | 10-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Tempest Pharmaceuticals.
Enhance accessibility to Tempest Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tempest Pharmaceuticals?
In 2016, Tempest Pharmaceuticals had a promoter holding of 4.00% and a public holding of 96.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivam Formulation Private LimitedActive 17 years 5 monthsBuddhadeb Chakraborty and Rishab Jaiswal are mutual person
- Sars Surya Construction Private LimitedActive 17 years 6 months
Buddhadeb Chakraborty and Rishab Jaiswal are mutual person
- Omkarnath Merchants Private LimitedActive 14 years 9 months
Buddhadeb Chakraborty and Rishab Jaiswal are mutual person
- Angler Sales Private LimitedActive 14 years 8 months
Buddhadeb Chakraborty and Rishab Jaiswal are mutual person
- Bluetooth Marketing Private LimitedActive 14 years 10 months
Buddhadeb Chakraborty and Rishab Jaiswal are mutual person
- Sonata Commosales Private LimitedActive 14 years 9 months
Buddhadeb Chakraborty and Rishab Jaiswal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tempest Pharmaceuticals?
Unlock and access historical data on people associated with Tempest Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tempest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tempest Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
